Search Page

1

Cite

Share

The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.

Chambers LM, Bussies P, Vargas R, Esakov E, Tewari S, Reizes O, Michener C. Chambers LM, et al. Curr Oncol Rep. 2021 Jun 14;23(8):92. doi: 10.1007/s11912-021-01079-x. Curr Oncol Rep. 2021. PMID: 34125319 Review.

Cite

Share

2

Cite

Share

CaMKIV regulates mitochondrial dynamics during sepsis.

Zhang X, Griepentrog JE, Zou B, Xu L, Cyr AR, Chambers LM, Zuckerbraun BS, Shiva S, Rosengart MR. Zhang X, et al. Among authors: chambers lm. Cell Calcium. 2020 Dec;92:102286. doi: 10.1016/j.ceca.2020.102286. Epub 2020 Sep 5. Cell Calcium. 2020. PMID: 32932146 Free PMC article.

Cite

Share

3

Cite

Share

Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature.

Kuznicki ML, Chambers LM, Morton M, Son J, Horowitz M, Crean-Tate KK, Hackett L, Rose PG. Kuznicki ML, et al. Among authors: chambers lm. J Minim Invasive Gynecol. 2021 Mar;28(3):513-526.e1. doi: 10.1016/j.jmig.2020.10.013. Epub 2020 Oct 24. J Minim Invasive Gynecol. 2021. PMID: 33223017

Cite

Share

4

Cite

Share

A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology.

Chambers LM, Costales AB, Crean-Tate K, Kuznicki M, Morton M, Horowitz M, Jagielo T, Rose PG, Michener C, Vargas R, Debernardo R. Chambers LM, et al. Gynecol Oncol. 2020 Sep;158(3):794-802. doi: 10.1016/j.ygyno.2020.06.487. Epub 2020 Jul 2. Gynecol Oncol. 2020. PMID: 32624234 Review.

Cite

Share

5

Cite

Share

Impact of antibiotic treatment on immunotherapy response in women with recurrent gynecologic cancer.

Chambers LM, Michener CM, Rose PG, Reizes O, Yao M, Vargas R. Chambers LM, et al. Gynecol Oncol. 2021 Apr;161(1):211-220. doi: 10.1016/j.ygyno.2021.01.015. Epub 2021 Jan 24. Gynecol Oncol. 2021. PMID: 33504455

Cite

Share

6

Cite

Share

To PARPI or Not to PARPI BRCA Mutated Ovarian Cancer Following First-line Chemotherapy, That is the Question?

Rose PG, Chambers LM, Kuznicki M. Rose PG, et al. Among authors: chambers lm. Gynecol Obstet (Sunnyvale). 2021;11(7):561. Epub 2021 Aug 3. Gynecol Obstet (Sunnyvale). 2021. PMID: 34925958 Free PMC article. No abstract available.

Cite

Share

7

Cite

Share

Survey of trends in authorship assignment in gynecologic oncology: Keeping score and playing fair.

Chambers LM, Watson CH, Yao M, Levinson K, Alvarez RD, Eskander RN, Buechel M, Michener CM, Jernigan A. Chambers LM, et al. Gynecol Oncol Rep. 2021 Mar 23;36:100755. doi: 10.1016/j.gore.2021.100755. eCollection 2021 May. Gynecol Oncol Rep. 2021. PMID: 33855146 Free PMC article.

Cite

Share

8

Cite

Share

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma.

Hunt JT, Chambers LM, Yao M, Joehlin-Price A, Debernardo R, Rose PG. Hunt JT, et al. Among authors: chambers lm. Gynecol Oncol Rep. 2021 Jul 24;37:100840. doi: 10.1016/j.gore.2021.100840. eCollection 2021 Aug. Gynecol Oncol Rep. 2021. PMID: 34401435 Free PMC article.

Cite

Share

9

Cite

Share

PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer.

Rose PG, Yao M, Chambers LM, Mahdi H, DeBernardo R, Michener CM, AlHilli M, Ricci S, Vargas R. Rose PG, et al. Among authors: chambers lm. Anticancer Drugs. 2021 Nov 1;32(10):1086-1092. doi: 10.1097/CAD.0000000000001219. Anticancer Drugs. 2021. PMID: 34520432

Cite

Share

10

Cite

Share

Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma.

Chambers LM, Chau D, Yao M, Costales AB, Rose PG, Michener CM, Debernardo R, Vargas R. Chambers LM, et al. Gynecol Oncol Rep. 2021 Oct 15;38:100876. doi: 10.1016/j.gore.2021.100876. eCollection 2021 Nov. Gynecol Oncol Rep. 2021. PMID: 34761096 Free PMC article.

Cite

Share